HL: Second-Line Sintilimab Plus Chemo Bests Chemo Alone ...Middle East

Use of the PD-1 inhibitor sintilimab in combination with ICE chemotherapy as a second-line treatment in classical Hodgkin lymphoma shows impressive response rates vs chemo alone in the phase 3 ORIENT-21 trial. Medscape Medical News

Hence then, the article about hl second line sintilimab plus chemo bests chemo alone was published today ( Monday 16/06/2025 - 11:25 AM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( HL: Second-Line Sintilimab Plus Chemo Bests Chemo Alone )

Also on site :

• PIN Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Pinterest, Inc.
• Sheena Easton, 66, Is Still a Stunning Redhead Several Years After Leaving the Chaos of Mega-Fame Behind
• ‘Murphy Brown’ Star Jessie Jones Dead at 75